Jacobi Capital Management LLC Astrazeneca PLC Transaction History
Jacobi Capital Management LLC
- $1.45 Billion
- Q2 2025
A detailed history of Jacobi Capital Management LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Jacobi Capital Management LLC holds 6,326 shares of AZN stock, worth $476,600. This represents 0.03% of its overall portfolio holdings.
Number of Shares
6,326
Previous 9,301
31.99%
Holding current value
$476,600
Previous $683,000
35.29%
% of portfolio
0.03%
Previous 0.05%
Shares
29 transactions
Others Institutions Holding AZN
# of Institutions
1,413Shares Held
506MCall Options Held
9.17MPut Options Held
3.07M-
Price T Rowe Associates Inc Baltimore, MD57.1MShares$4.3 Billion0.52% of portfolio
-
Primecap Management CO Pasadena, CA41.2MShares$3.1 Billion2.35% of portfolio
-
Wellington Management Group LLP Boston, MA35.6MShares$2.68 Billion0.52% of portfolio
-
Bank Of America Corp Charlotte, NC31.8MShares$2.4 Billion0.19% of portfolio
-
Capital International Investors Los Angeles, CA31.4MShares$2.37 Billion0.39% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $233B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...